Jarrad Aguirre

Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom.

Enduring, Inc. is an American company that helps individuals manage their blood pressure, cholesterol, and weight for a monthly fee of $9.99. The first three months are free and customers can cancel at any time. The company was founded by Jarrad Aguirre and Dre Limberopoulos, with Jarrad Aguirre serving as CEO since incorporation.